|
CA2275527C
(en)
|
1996-12-19 |
2003-09-23 |
Hoechst Marion Roussel, Inc. |
Novel heterocyclic substituted pyrrolidine amide derivatives
|
|
EP1213296B1
(en)
|
1999-08-31 |
2004-04-14 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
|
|
HUP0202626A3
(en)
|
1999-09-27 |
2004-09-28 |
Pioneer Hi Bred Internat Inc J |
Enhanced stress tolerance in maize via manipulation of cell cycle regulatory genes
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
WO2002044192A1
(en)
|
2000-11-30 |
2002-06-06 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
|
|
SK287786B6
(sk)
|
2000-12-28 |
2011-09-05 |
Kissei Pharmaceutical Co., Ltd. |
Glukopyranosyloxypyrazolový derivát, farmaceutická kompozícia alebo kombinácia s jeho obsahom a ich použitie
|
|
PL210710B1
(pl)
|
2002-03-22 |
2012-02-29 |
Kissei Pharmaceutical |
Krystaliczne postaci 2-(4-metoksybenzylo) fenylo-6-O-etoksykarbonylo-ß-D-glukopiranozydu, ich zastosowanie oraz zawierająca je kompozycja farmaceutyczna
|
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
CA2510807C
(en)
|
2002-12-19 |
2011-11-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of tace
|
|
CA2515132C
(en)
|
2003-02-07 |
2012-01-03 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl substituted pyrroles useful as inhibitors of protein kinases
|
|
ATE510834T1
(de)
|
2003-03-14 |
2011-06-15 |
Astellas Pharma Inc |
C-glykosid-derivate zur behandlung von diabetes
|
|
CN104109155A
(zh)
|
2003-08-01 |
2014-10-22 |
田边三菱制药株式会社 |
新颖化合物
|
|
WO2005020921A2
(en)
|
2003-08-29 |
2005-03-10 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
EA011158B1
(ru)
|
2004-03-16 |
2009-02-27 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
|
|
EP1791835A2
(en)
|
2004-09-09 |
2007-06-06 |
Astellas Pharma Inc. |
Thiazole derivatives having vap-1 inhibitory activity
|
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
|
HRP20140975T1
(hr)
|
2005-10-07 |
2014-11-21 |
Exelixis, Inc. |
Derivati n-(3-amino-hinoksalin-2-il)-sulfonamida i njihova uporaba kao inhibitora fosfatidilinozitol 3-kinaze
|
|
AR059489A1
(es)
|
2006-02-15 |
2008-04-09 |
Boehringer Ingelheim Vetmed |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
US20070293548A1
(en)
|
2006-03-31 |
2007-12-20 |
Wang Eric Y |
Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
|
|
WO2007140191A2
(en)
|
2006-05-23 |
2007-12-06 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法
|
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
|
CA2671984A1
(en)
|
2006-12-11 |
2008-06-19 |
Boehringer Ingelheim International Gmbh |
New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
|
|
TW200904405A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
|
UA107175C2
(uk)
|
2007-07-26 |
2014-12-10 |
|
Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти
|
|
US20090054392A1
(en)
|
2007-08-20 |
2009-02-26 |
Wyeth |
Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
|
MX2010002695A
(es)
|
2007-09-10 |
2010-04-01 |
Janssen Pharmaceutica Nv |
Proceso para la preparacion de compuestos utiles como inhibidores de transportador de glucosa dependiente de sodio (sglt).
|
|
TW201011043A
(en)
|
2008-06-20 |
2010-03-16 |
Chugai Pharmaceutical Co Ltd |
Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
|
|
TWI472521B
(zh)
|
2008-07-17 |
2015-02-11 |
Lexicon Pharmaceuticals Inc |
(2s,3r,4r,5s,6r)-2-(4-氯-3-(4-乙氧苄基)苯基)-6-(甲硫)四氫-2h-哌喃-3,4,5-三醇的固體形態與其使用方法
|
|
AR076317A1
(es)
|
2009-04-16 |
2011-06-01 |
Taisho Pharmaceutical Co Ltd |
Composiciones farmaceuticas que comprenden un compuesto de 1-tio-d-glucitol.
|
|
EP2479165B1
(en)
|
2009-09-16 |
2017-10-25 |
Astellas Pharma Inc. |
Glycine compound
|
|
ES2596202T3
(es)
|
2009-09-30 |
2017-01-05 |
Boehringer Ingelheim International Gmbh |
Método para la preparación de una forma cristalina de 1-cloro-4-(ß-D-glucopiranos-1-il)-2-[4-((S)-tetrahidrofuran-3-iloxi)-bencil]-benceno
|
|
DK2486029T3
(en)
|
2009-09-30 |
2015-08-24 |
Boehringer Ingelheim Int |
Methods of making of glucopyranosyl-substituted benzyl-benzene derivatives.
|
|
FI20115234A0
(fi)
|
2011-03-08 |
2011-03-08 |
Biotie Therapies Corp |
Uusia pyridatsinoni- ja pyridoniyhdisteitä
|
|
KR101879011B1
(ko)
|
2011-03-15 |
2018-07-16 |
아스테라스 세이야쿠 가부시키가이샤 |
구아니딘 화합물
|
|
CA2871793C
(en)
|
2012-05-02 |
2020-09-15 |
Pharmaxis Ltd. |
Substituted 3-haloallylamine inhibitors of ssao and uses thereof
|
|
BR112017004589A2
(pt)
|
2014-09-10 |
2018-01-23 |
Epizyme Inc |
composto, composição farmacêutica, método para tratar um paciente, uso de um composto, kit, e método para tratar um distúrbio mediado por proteína smyd
|
|
EP3333163A4
(en)
|
2015-08-06 |
2019-01-09 |
UBE Industries, Ltd. |
SUBSTITUTED GUANIDINE DERIVATIVE
|
|
WO2017148519A1
(en)
|
2016-03-03 |
2017-09-08 |
Boehringer Ingelheim International Gmbh |
Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as aoc3 inhibitors
|
|
SI3455216T1
(sl)
|
2016-05-12 |
2021-02-26 |
Boehringer Ingelheim International Gmbh |
Piridinilni derivati, farmacevtski sestavki in njihove uporabe kot AOC3 inhibitorji
|
|
WO2018027892A1
(en)
|
2016-08-12 |
2018-02-15 |
Eli Lilly And Company |
Amino pyrimidine ssao inhibitors
|
|
MX389800B
(es)
|
2017-02-07 |
2025-03-20 |
Oblique Therapeutics Ab |
Piridinas sustituidas con heterociclilsulfonilo y su uso en el tratamiento del cancer
|
|
WO2018148856A1
(en)
*
|
2017-02-14 |
2018-08-23 |
Eli Lilly And Company |
Diazaspirodecanyl-pyrimidine compounds useful as ssao inhibitors
|
|
WO2018196677A1
(zh)
|
2017-04-28 |
2018-11-01 |
四川科伦博泰生物医药股份有限公司 |
氟代烯丙胺衍生物及其用途
|
|
FI3626699T3
(fi)
|
2017-06-20 |
2023-08-15 |
Shandong Danhong Pharmaceutical Co Ltd |
Ssao:n estäjä
|
|
CN109251166B
(zh)
|
2017-07-13 |
2021-11-05 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其在医药上的应用
|
|
CN110914234B
(zh)
|
2017-08-04 |
2023-06-23 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其在医药上的应用
|
|
CN109810041B
(zh)
|
2017-11-21 |
2023-08-15 |
药捷安康(南京)科技股份有限公司 |
卤代烯丙基胺类ssao/vap-1抑制剂及其应用
|
|
US20210113561A1
(en)
|
2018-04-17 |
2021-04-22 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
JP7425793B2
(ja)
|
2018-10-29 |
2024-01-31 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ピリジニルスルホンアミド誘導体、医薬組成物およびそれらの使用
|
|
CA3112510A1
(en)
|
2018-10-29 |
2020-05-07 |
Boehringer Ingelheim International Gmbh |
Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
|